Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,525 | -5,001 | -3,556 | -4,523 | -2,549 |
| Depreciation Amortization | 50 | 114 | 111 | 427 | 155 |
| Other Working Capital | 468 | -114 | 540 | -140 | -361 |
| Other Operating Activity | 791 | 1,297 | 911 | 1,438 | 1,406 |
| Operating Cash Flow | $-4,217 | $-3,704 | $-1,994 | $-2,799 | $-1,349 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,803 | 4,925 | 1,599 | -9,910 | N/A |
| PPE Investments | N/A | -150 | -2 | N/A | N/A |
| Investing Cash Flow | $2,803 | $4,776 | $1,597 | $-9,910 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 100 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 1,328 |
| Common Stock Issued | 1,964 | N/A | N/A | 12,578 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -100 | -104 |
| Financing Cash Flow | $1,964 | $N/A | $N/A | $12,578 | $1,223 |
| Exchange Rate Effect | 1 | 1 | 71 | 1 | -2 |
| Beginning Cash Position | 1,288 | 215 | 541 | 671 | 799 |
| End Cash Position | 1,839 | 1,288 | 215 | 541 | 671 |
| Net Cash Flow | $551 | $1,073 | $-326 | $-130 | $-128 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,217 | -3,704 | -1,994 | -2,799 | -1,349 |
| Capital Expenditure | N/A | -150 | -2 | N/A | N/A |
| Free Cash Flow | -4,217 | -3,854 | -1,996 | -2,799 | -1,349 |